Pyralvex solution

Pyralvex is a well-established medicinal treatment used primarily for mouth ulcers and denture irritation. It was originally developed as a professional pharmaceutical solution combining salicylic acid and rhubarb extract to provide analgesic and antiseptic properties for oral mucosa. The brand has a long history in European medicine cabinets as a trusted remedy for gingivitis and oral inflammation.

Over the decades, the brand's ownership has shifted through several pharmaceutical mergers and acquisitions. Originally associated with legacy European pharma firms, it eventually became part of the Norgine portfolio. Norgine is a leading European specialist pharmaceutical company that has managed the brand's distribution and manufacturing for many years. Most production is concentrated in modern pharmaceutical facilities in Germany, ensuring compliance with strict healthcare regulations.

Today, Pyralvex remains a core product within Norgine's consumer healthcare segment. The brand is distributed across various international markets, often through local subsidiaries or specialized pharmaceutical distributors, maintaining its status as a staple oral care treatment.